The hydroxychloroquine for COVID-19 market is anticipated to grow at a significant CAGR of 3.4% during the forecast period (2022-2028). Hydroxychloroquine raises endosomal pH, which prevents SARS-CoV-2 from fusing to the host cell membrane. Chloroquine prevents the cellular angiotensin-converting enzyme 2 (ACE2) receptor from being glycosylated, which may prevent SARS-CoV from attaching to the cell […]